The Emergency Medicine Specimen Bank: An Innovative Approach To Biobanking In Acute Care.

The Emergency Medicine Specimen Bank (EMSB) was developed to facilitate precision medicine in acute care. The EMSB is a biorepository of clinical health data and biospecimens collected from all adult English- or Spanish-speaking individuals who are able and willing to provide consent and are treated at the UCHealth-University of Colorado Hospital Emergency Department. The EMSB is the first acute care biobank that seeks to enroll all patients, with all conditions who present to the ED. Acute care biobanking presents many challenges that are unique to acute care settings such as providing informed consent in a uniquely stressful and fast-paced environment and collecting, processing, and storing samples for tens of thousands of patients per year. Here, we describe the process by which the EMSB overcame these challenges and was integrated into clinical workflow allowing for operation 24 hours a day, 7 days a week at a reasonable cost. Other institutions can implement this template, further increasing the power of biobanking research to inform treatment strategies and interventions for common and uncommon phenotypes in acute care settings.

[1]  M. Cazzola,et al.  How does race/ethnicity influence pharmacological response to asthma therapies? , 2018, Expert opinion on drug metabolism & toxicology.

[2]  J. Vincent,et al.  The coming era of precision medicine for intensive care , 2017, Critical Care.

[3]  A. D’Alessandro,et al.  Characterization of rapid extraction protocols for high-throughput metabolomics. , 2017, Rapid communications in mass spectrometry : RCM.

[4]  Timothy Caulfield,et al.  Genes, cells, and biobanks: Yes, there’s still a consent problem , 2017, PLoS biology.

[5]  A. Kurian,et al.  The Changing Landscape of Genetic Testing for Inherited Breast Cancer Predisposition , 2017, Current Treatment Options in Oncology.

[6]  “Common Rule,et al.  Federal Policy for the Protection of Human Subjects. Final rule. , 2017, Federal register.

[7]  E. Tsalik,et al.  Systematic Molecular Phenotyping: A Path Toward Precision Emergency Medicine? , 2016, Academic emergency medicine : official journal of the Society for Academic Emergency Medicine.

[8]  Jim Vaught,et al.  Biobanking Comes of Age: The Transition to Biospecimen Science. , 2016, Annual review of pharmacology and toxicology.

[9]  Alla Karnovsky,et al.  Whole Blood Reveals More Metabolic Detail of the Human Metabolome than Serum as Measured by 1H-NMR Spectroscopy: Implications for Sepsis Metabolomics , 2015, Shock.

[10]  Euan A Ashley,et al.  The precision medicine initiative: a new national effort. , 2015, JAMA.

[11]  Joshua LaBaer,et al.  Statistical design for biospecimen cohort size in proteomics-based biomarker discovery and verification studies. , 2013, Journal of proteome research.

[12]  Eun Pyo Hong,et al.  Sample Size and Statistical Power Calculation in Genetic Association Studies , 2012, Genomics & informatics.

[13]  D. Angiolillo,et al.  Impact of race and gender on antithrombotic therapy , 2010, Thrombosis and Haemostasis.

[14]  K. Ferdinand,et al.  Race-based therapy for hypertension: possible benefits and potential pitfalls , 2008, Expert review of cardiovascular therapy.